JAAD Online Supplement: Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study

Published: 21 April 2021| Version 1 | DOI: 10.17632/2jhhh83yxb.1
Contributor:
Ai-Tram Bui

Description

Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study - JAAD Supplemental Figure

Files

Categories

Natural Sciences

Licence